Regions of low oxygen (hypoxia) are frequently found in solid tumours. Clinically, hypoxia is associated with worse patient survival and resistance to chemotherapy and radiotherapy. Therefore developing new strategies to target the hypoxic microenvironment is critical for improving patient outcome. HIF1α and HIF2α are transcription factors that are stabilised in hypoxia leading to changes in key genes which trigger more aggressive growth, survival and metastasis, and contribute to the major hallmarks of cancer. Additional epigenetic regulations are required, for the transcriptional adaptations that occur in hypoxia this project aims to investigate these. This work will lead to novel approaches to targeting the hypoxic regions of solid tumours (in particular our work focuses on breast, colon and brain tumours, however other solid tumours are also relevant).
Available to Home/EU/International students.
University of NottinghamMedical School Nottingham, NG7 2UH
Contacts: For admissions enquiries, call 0115 951 5559. For other enquiries, call 0115 823 0031 ext.30031 or please see our 'contact us' page for further details